Cutting edge: Productive HIV-1 infection of dendritic cells via complement receptor type 3 (CR3, CD11b/CD18)

Journal of Immunology

Volumn 173, Issue 8, 2004, Pages 4775-4778

  Bajtay, Zsuzsa ^a   Speth, Cornelia ^a   Erdei, Anna ^b   Dierich, Manfred P ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b EÖTVÖS LORÁND UNIVERSITY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD18 ANTIGEN; COMPLEMENT RECEPTOR; COMPLEMENT RECEPTOR TYPE 3; COMPLEMENT RECEPTOR TYPE 4; EDETIC ACID; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; UNCLASSIFIED DRUG;

ARTICLE; CELL MATURATION; CONTROLLED STUDY; DENDRITIC CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIGAND BINDING; MONOCYTE; OPSONIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 6344261596     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.8.4775     Document Type: Article

References (29)

1. Ebenbichler, C. F., N. M. Thielens, R. Vornhagen, P. Marschang, G. J. Arlaud, and M. P. Dierich. 1991. Human immunodeficiency virus type 1 activates the classical pathway of complement by direct C1 binding through specific sites in the transmembrane glycoprotein gp41. J. Exp. Med. 174:1417.
2. Dierich, M. P., C. F. Ebenbichler, P. Marschang, G. Fust, N. M. Thielens, and G. J. Arlaud. 1993. HIV and human complement: mechanisms of interaction and biological implication. Immunol. Today 14:435.
3. Delibrias, C. C, M. D. Kazatchkine, and E. Fischer. 1993. Evidence for the role of CR1 (CD35), in addition to CR2 (CD21), in facilitating infection of human T cells with opsonized HIV. Scand. J. Immunol. 38:183.
4. Legendre, C., G. Gras, R. Krzysiek, Galanaud, Y. Richard, and D. Dormont. 1996. Mechanisms of opsonized HIV entry in normal B lymphocytes. FEBS Lett. 381:227.
5. Thieblemont, N., N. Haeffher-Cavaillon, A. Ledur, J. L'Age-Stehr, H. W. Ziegler-Heitbrock, and M. D. Kazatchkine. 1993. CR1 (CD35) and CR3 (CD11b/CD18) mediate infection of human monocytes and monocytic cell lines with complement-opsonized HIV independently of CD4. Clin. Exp. Immunol. 92:106.
6. Erdei, A., G. Füst, and J. Gergely. 1991. The role of C3 in the immune response. Immunol. Today 12:332.
7. Gordon, S. 2002. Pattern recognition receptors: doubling up for the innate immune response. Cell 111:927.
8. Grassi, F., C. Dezutter-Dambuyant, D. McIlroy, C. Jacquet, K. Yoneda, S. Imamura, L. Boumsell, D. Schmitt, B. Autran, P. Debre, and A. Hosmalin. 1998. Monocyte-derived dendritic cells have a phenotype comparable to that of dermal dendritic cells and display ultrastructural granules distinct from Birbeck granules. J. Leukocyte Biol. 64:484.
9. Hildreth, J. E., and R. J. Orentas. 1989. Involvement of a leukocyte adhesion receptor (LFA-1) in HIV-induced syncytium formation. Science 244:1075.
10. Stoiber, H., I. Frank, M. Spruth, M. Schwendinger, B. Mullauer, J. M. Windisch, R. Schneider, H. Katinger, I. Ando, and M. P. Dierich. 1997. Inhibition of HIV-1 infection in vitro by monoclonal antibodies to the complement receptor type 3 (CR3): an accessory role for CR3 during virus entry? Mol. Immunol. 34:855.
11. Banchereau, J., F. Briere, C. Caux, J. Davoust, S. Lebecque, Y. J. Liu, B. Pulendran, and K. Palucka. 2000. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18:767.
12. Zaitseva, M., A. Blauvelt, S. Lee, C. K. Lapham, V. Klaus-Kovtun, H. Mostowski, J. Manischewitz, and H. Golding. 1997. Expression and function of CCR5 and CXCR4 on human Langerhans cells and macrophages: implications for HIV primary infection. Nat. Med. 3:1369.
13. Granelli-Piperno, A, E. Delgado, V. Finkel, W. Paxton, and R. M. Steinman. 1998. Immature dendritic cells selectively replicate macrophagetropic (M-tropic) human immunodeficiency virus type 1, while mature cells efficiently transmit both M- and T-tropic virus to T cells. J. Virol. 72:2733.
14. Uciechowski, P., and R. E. Schmidt. 1989. White cell differentiation antigens. In Leukocyte Typing IV. W. Knapp, B. Dörken, W. R. Gilks, E. P. Rieber, R. E. Schmidt, H. Stein, and A. E. G. von dem Borne, eds. Oxford Univ. Press, Oxford, U.K., p. 543.
15. Romani, N., S. Gruner, D. Brang, E. Kampgen, A. Lenz, B. Trockenbacher, G. Konwalinka, P. O. Fritsch, R. M. Steinman, and G. Schuler. 1994. Proliferating dendritic cell progenitors in human blood. J. Exp. Med. 180:83.
16. Sallusto, F., and A. Lanzavecchia. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α. J. Exp. Med. 179:1109.
17. Freundlich, B., and N. Avdalovic. 1983. Use of gelatin/plasma coated flasks for isolating human peripheral blood monocytes. J. Immunol. Methods 62:31.
18. Kacani, L., I. Frank, M. Spruth, M. G. Schwendinger, B. Mullauer, G. M. Sprinzl, F. Steindl, and M. P. Dierich. 1998. Dendritic cells transmit human immunodeficiency virus type 1 to monocytes and monocyte-derived macrophages. J. Virol. 72:6671.
19. Purtscher, M., A. Trkola, G. Gruber, A. Buchacher, R. Predl, F. Steindl, C. Tauer, R. Berger, N. Barrett, and A. Jungbauer. 1994. A broadly neutralizing human monoclonal antibody against gp41 of human immunodeficiency virus type 1. AIDS Res. Hum. Retroviruses 10:1651.
20. Hart, D. N., and J. L. McKenzie. 1988. Isolation and characterization of human tonsil dendritic cells. J. Exp. Med. 168:157.
21. Stingl, G., E. C Wolff-Schreiner, W. J. Pichler, F. Gschnait, W. Knapp, and K. Wolff. 1977. Epidermal Langerhans cells bear Fc and C3 receptors. Nature 268:245.
22. Bouhlal, H., J. Galon, M. D. Kazatchkine, W. H. Fridman, C. Sautes-Fridman, and N. Haeffner Cavaillon. 2001. Soluble CD16 inhibits CR3 (CD11b/CD18)-mediated infection of monocytes/macrophages by opsonized primary R5 HIV-1. J. Immunol. 166:3377.
23. Geijtenbeek, T. B., S. J. van Vliet, A. Engering, B. A. 't Hart, and Y. van Kooyk. 2004. Self- and nonself-recognition by C-type lectins on dendritic cells. Annu. Rev. Immunol. 22:33.
24. + T cells of HIV infected individuals: a possible role in AIDS pathogenesis. Int. Immunol. 6:1361.
25. June, R. A., S. Z. Schade, M. J. Bankowski, M. Kuhns, A. McNamara, T. F. Lint, A. L. Landay, and G. T. Spear. 1991. Complement and antibody mediate enhancement of HIV infection by increasing virus binding and provirus formation. AIDS 5:269.
26. Sullivan, B. L., E. J. Knopoff, M. Saifuddin, D. M. Takefman, M. N. Saarloos, B. E. Sha, and G. T. Spear. 1996. Susceptibility of HIV-1 plasma virus to complement-mediated lysis: evidence for a role in clearance of virus in vivo. J. Immunol. 157:1791.
27. Stoiber, H., C. Speth, and M. P. Dierich. 2003. Role of complement in the control of HIV dynamics and pathogenesis. Vaccine 21 (Suppl. 2):77. Review.
28. Montefiori, D. C., R. J. Cornell, J. Y. Zhou, J. T. Zhou, V. M. Hirsch, and P. R. Johnson. 1994. Complement control proteins, CD46, CD55, and CD59, as common surface constituents of human and simian immunodeficiency viruses and possible targets for vaccine protection. Virology 205:82.
29. Shi, C., X. Zhang, Z. Chen, M. K. Robinson, and D. I. Simon. 2001. Leukocyte integrin Mac-1 recruits Toll/interleukin-1 receptor superfamily signaling intermediates to modulate NF-κB activity. Circ. Res. 89:859.